Angiotensin II

Overview and Clinical Significance

Angiotensin II is a potent vasoconstrictor that plays a central role in the renin-angiotensin-aldosterone system (RAAS), regulating blood pressure, fluid balance, and electrolyte homeostasis. It is formed from angiotensin I by the action of angiotensin-converting enzyme (ACE).

Clinical Significance

  • Blood Pressure Regulation: Angiotensin II constricts blood vessels, increasing blood pressure and maintaining circulatory stability.
  • Heart Failure and Shock: Used as a vasopressor in refractory hypotension, particularly in septic shock patients who do not respond to catecholamines.
  • Kidney Function: Influences glomerular filtration rate (GFR) and sodium retention, affecting fluid balance and renal health.
  • Cardiovascular Remodeling: Excessive angiotensin II activity contributes to hypertension, heart failure, and vascular damage.
  • Therapeutic Target: ACE inhibitors and angiotensin receptor blockers (ARBs) are widely used to reduce angiotensin II effects, treating hypertension and heart disease.

Angiotensin II is a key regulator of vascular tone and fluid homeostasis, with significant implications for cardiovascular and renal health.

Increasing +

Decreasing -

Hypertension & Kidney Disease

  • Persistent Elevation:
    Chronic high levels of angiotensin II are linked to high blood pressure, chronic kidney disease, and conditions that activate the renin–angiotensin system (RAS).

Inflammatory Effects

  • Pro-Inflammatory Role:
    Angiotensin II is pro-inflammatory and might contribute to endothelial dysfunction in autoimmune vasculitis or chronic inflammatory states.

Pharmacologic Intervention & RAS Underactivity

  • Pharmacologic Intervention:
    Use of ACE inhibitors or ARBs will reduce angiotensin II levels.
  • RAS Underactivity:
    Rare conditions with reduced renin production may lead to low angiotensin II.

More Info

Related

Age-Related and Pregnancy Influences on RAS

  • Aging Effects:
    Changes in vascular reactivity and kidney function with aging may alter baseline angiotensin II.
  • Physiologic Adjustments in Pregnancy:
    Pregnancy can influence RAS components, though typically in a well-regulated manner.

Renin–Angiotensin–Aldosterone System (RAAS)

All these markers are components of the Renin–Angiotensin–Aldosterone System (RAAS), which regulates blood pressure, fluid balance, and electrolyte homeostasis:

  • Renin is produced by the kidneys and initiates the process by converting angiotensinogen into angiotensin I.
  • Angiotensin I serves as a precursor that is converted by Angiotensin Converting Enzyme (ACE) into the active Angiotensin II.
  • Angiotensin II is a potent vasoconstrictor that also stimulates the adrenal cortex to secrete Aldosterone.
  • Aldosterone, measured in both blood and urine, acts on the kidneys to enhance sodium and water retention, thereby increasing blood volume and pressure.

Together, these components work in a coordinated cascade to maintain cardiovascular stability and fluid balance.

All Markers